
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Record-breaking 'space laser' erupts from merging galaxies 8 billion light-years away - 2
NASA releases new ‘Earthset’ and eclipse images taken during historic flyby of the moon - 3
Deadly heat worldwide prompts $300 million for climate health research at COP30 - 4
Glen Powell will host 'Saturday Night Live' with Olivia Dean as musical guest: What to know ahead of their debut - 5
EU Commission prepares €90bn Ukraine loan despite Hungary's veto
Vehicle Lovers' Decision: Purchase A Reasonable Vehicle
Want to read more in 2026? Here's how to revive your love of books
A coup too far: Why Benin's rebel soldiers failed where others in the region succeeded
The largest sun of 2026 rises today as Earth draws closest to our parent star
Investigating Design and Individual Style: Track down Your Remarkable Look
Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25
What to know about Jack Dorsey's new Vine revival, DiVine
Smartwatches: Remain Associated and Dynamic
Conquering Social Generalizations: Individual Accounts of Strengthening












